Trump, FDA zero in on foreign factories to give domestic sites an edge news2025-05-06T17:35:14+00:00May 6th, 2025|Endpoints News|
Controversial doctor Vinay Prasad named CBER director at FDAnews2025-05-06T16:31:21+00:00May 6th, 2025|Endpoints News|
New opioid data may not be generalizable, FDA adcomm saysnews2025-05-05T20:55:13+00:00May 5th, 2025|Endpoints News|
FDA adcomm to review Capricor’s Duchenne cell therapynews2025-05-05T20:07:53+00:00May 5th, 2025|Endpoints News|
BioNTech doesn’t see ‘near-term’ impact from RFK Jr.’s vaccine policy proposalnews2025-05-05T17:25:45+00:00May 5th, 2025|Endpoints News|
The big question for the FDA after Stealth’s PDUFA delaynews2025-05-05T11:00:41+00:00May 5th, 2025|Endpoints News|
After FDA firings, drug reviewers are asked to volunteer for administrative worknews2025-05-02T19:08:02+00:00May 2nd, 2025|Endpoints News|
White House budget proposes billions in cuts at NIH, CDCnews2025-05-02T18:17:26+00:00May 2nd, 2025|Endpoints News|
FDA withdraws compliance deadlines for makers of bone allograftsnews2025-05-02T15:43:57+00:00May 2nd, 2025|Endpoints News|
Cytokinetics’ stock drops after heart drug PDUFA pushed back due to lack of REMSnews2025-05-02T10:20:53+00:00May 2nd, 2025|Endpoints News|
